Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 report provides the reader with the following key benefits:
In-depth understanding of collaborative R&D deal trends since 2012
Analysis of the structure of collaborative R&D agreements with numerous real life case studies
Comprehensive listing of all collaborative R&D deals since 2012, together with deal terms, value and press release
Comprehensive access to actual collaborative R&D contracts entered into by the world’s life science companies
Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
Insight into the terms included in a collaborative R&D agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
'
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in collaborative R&D dealmaking
2.1. Introduction
2.2. Definition of collaborative R&D partnering
2.3. Success factors for collaborative R&D deals
2.4. When collaborative R&D can be useful
2.5. Attributes of collaborative R&D deals
2.6. Trends in collaborative R&D deals since 2012
2.6.1. Collaborative R&D dealmaking by year, 2012 to 2018
2.6.2. Collaborative R&D dealmaking by phase of development, 2012 to 2018
2.6.3. Collaborative R&D dealmaking by industry sector, 2012 to 2018
2.6.4. Collaborative R&D dealmaking by therapy area, 2012 to 2018
2.6.5. Collaborative R&D dealmaking by technology type, 2012 to 2018
2.6.6. Collaborative R&D dealmaking by most active company, 2012 to 2018
2.7. The future of collaborative R&D deals
Chapter 3 – Overview of collaborative R&D deal structure
3.1. Introduction
3.2. Pure versus multi-component collaborative R&D deals
3.3. Pure collaborative R&D agreement structure
3.3.1. Example collaborative R&D agreements
3.3.1.a. Case study 1: Marinus Pharmaceuticals - NovaMedica
3.3.1.b. Case study 2: Idenix Pharmaceuticals – Janssen Pharmaceuticals
3.4. Collaborative R&D as part of a wider alliance agreement
3.4.1. Example collaborative R&D agreements and their licensing clauses
3.4.1.a. Case study 3: 4D Molecular Therapeutics – UniQure
3.4.1.b. Case study 4: Kyowa Hakko Kirin – Ultragenyx Pharmaceuticals
3.4.2. Example licensing option right clauses in collaborative R&D deals
3.4.2.a. Case study 5: Forest Laboratories - Trevena
3.4.2.b. Case study 6: Abbvie – Receptos
Chapter 4 – Leading collaborative R&D deals
4.1. Introduction
4.2. Top collaborative R&D deals by value
Chapter 5 – Top 50 most active collaborative R&D dealmakers
5.1. Introduction
5.2. Top 50 most active collaborative R&D dealmakers
Chapter 6 – Collaborative R&D deal term financials
6.1. Introduction
6.2. Collaborative R&D partnering headline values
6.3. Collaborative R&D deal upfront payments
6.4. Collaborative R&D deal milestone payments
6.5. Collaborative R&D royalty rates
Chapter 7 – Collaborative R&D contract directory 2012 - 2018
7.1. Introduction
7.2. Collaborative R&D deals with contracts 2012 to 2018
Appendices
Appendix 1 – Collaborative R&D dealmaking by companies A-Z
Appendix 2 – Collaborative R&D dealmaking by industry sector
Appendix 3 – Collaborative R&D dealmaking by stage of development
Appendix 4 – Collaborative R&D dealmaking by therapy area
Appendix 5 – Collaborative R&D dealmaking by technology type
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering
TABLE OF FIGURES
Figure 1: Definition of collaborative R&D
Figure 2: Situations where collaborative R&D can prove useful
Figure 3: Key attributes of a collaborative R&D deal
Figure 4: Trends in Collaborative R&D deal announcements, 2012 to 2018
Figure 5: Collaborative R&D deals signed at each phase of development, 2012 to 2018
Figure 6: Collaborative R&D deals by industry sector, 2012 to 2018
Figure 7: Collaborative R&D deals by therapy area, 2012 to 2018
Figure 8: Collaborative R&D deals by technology type, 2012 to 2018
Figure 9: Top 50 most active collaborative R&D dealmakers, 2012 to 2018
Figure 10: Collaborative R&D agreements – what should a contract include?
Figure 11: Components of the collaborative R&D deal structure
Figure 12: Top collaborative deals by value 2012 to 2018
Figure 13: Most active collaborative R&D dealmakers 2012 to 2018
Figure 14: Collaborative R&D deals with a headline value
Figure 15: Collaborative R&D deals with an upfront value
Figure 16: Collaborative R&D deals with a milestone value
Figure 17: Collaborative R&D deals with a royalty rate value